Literature DB >> 25561348

Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.

Morten O Holmström1, Peter Gimsing, Niels Abildgaard, Niels F Andersen, Carsten Helleberg, Niels Aage T Clausen, Tobias W Klausen, Mikael Frederiksen, Dan L Kristensen, Herdis Larsen, Per T Pedersen, Kristian Thidemann Andersen, Robert Schou Pedersen, Bo Amdi Jensen, Henrik Gregersen, Annette J Vangsted.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25561348     DOI： 10.1002/ajh.23932

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  15 in total

Review 1.  Clinical Considerations for Immunoparesis in Multiple Myeloma.

Authors:  Michael Chahin; Zachery Branham; Ashley Fox; Christian Leurinda; Amany R Keruakous
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

Review 2.  Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.

Authors:  Shakira J Grant; Hira S Mian; Smith Giri; Melina Boutin; Lorenzo Dottorini; Nina R Neuendorff; Jessica L Krok-Schoen; Nikita Nikita; Ashley E Rosko; Tanya M Wildes; Sonja Zweegman
Journal:  J Geriatr Oncol       Date:  2020-12-17       Impact factor: 3.599

Review 3.  The Danish National Multiple Myeloma Registry.

Authors:  Peter Gimsing; Morten O Holmström; Tobias Wirenfelt Klausen; Niels Frost Andersen; Henrik Gregersen; Robert Schou Pedersen; Torben Plesner; Per Trøllund Pedersen; Mikael Frederiksen; Ulf Frølund; Carsten Helleberg; Annette Vangsted; Peter de Nully Brown; Niels Abildgaard
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

4.  Recognition of early mortality in multiple myeloma by a prediction matrix.

Authors:  Howard Terebelo; Shankar Srinivasan; Mohit Narang; Rafat Abonour; Cristina Gasparetto; Kathleen Toomey; James W Hardin; Gail Larkins; Amani Kitali; Robert M Rifkin; Jatin J Shah
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

5.  Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.

Authors:  Nicole Balmaceda; Muhammad Aziz; Viveksandeep Thoguluva Chandrasekar; Brian McClune; Suman Kambhampati; Leyla Shune; Al-Ola Abdallah; Faiz Anwer; Aneela Majeed; Muzaffar Qazilbash; Siddhartha Ganguly; Joseph McGuirk; Ghulam Rehman Mohyuddin
Journal:  BMC Cancer       Date:  2021-06-26       Impact factor: 4.430

6.  Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma.

Authors:  Pei Hsu; Ting-Wei Lin; Jyh-Pyng Gau; Yuan-Bin Yu; Liang-Tsai Hsiao; Cheng-Hwai Tzeng; Po-Min Chen; Tzeon-Jye Chiou; Jin-Hwang Liu; Yao-Chung Liu; Chia-Jen Liu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

7.  Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.

Authors:  Rasmus Sørrig; Tobias W Klausen; Morten Salomo; Annette J Vangsted; Ulf Christian Frølund; Kristian T Andersen; Anja Klostergaard; Carsten Helleberg; Robert S Pedersen; Per T Pedersen; Sissel Helm-Petersen; Elena Manuela Teodorescu; Birgitte Preiss; Niels Abildgaard; Peter Gimsing
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

8.  Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice.

Authors:  Jun Xia; Lingling Wang; Xin Zhou; Jing Wang; Huan Wang; Hongfeng Guo
Journal:  J Int Med Res       Date:  2018-03-27       Impact factor: 1.671

9.  Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.

Authors:  Mark T Drayson; Stella Bowcock; Tim Planche; Gulnaz Iqbal; Guy Pratt; Kwee Yong; Jill Wood; Kerry Raynes; Helen Higgins; Bryony Dawkins; David Meads; Claire T Hulme; Irene Monahan; Kamaraj Karunanithi; Helen Dignum; Edward Belsham; Jeff Neilson; Beth Harrison; Anand Lokare; Gavin Campbell; Michael Hamblin; Peter Hawkey; Anna C Whittaker; Eric Low; Janet A Dunn
Journal:  Lancet Oncol       Date:  2019-10-23       Impact factor: 41.316

Review 10.  Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN).

Authors:  Evangelos Terpos; Monika Engelhardt; Gordon Cook; Francesca Gay; Maria-Victoria Mateos; Ioannis Ntanasis-Stathopoulos; Niels W C J van de Donk; Hervé Avet-Loiseau; Roman Hajek; Annette Juul Vangsted; Heinz Ludwig; Sonja Zweegman; Philippe Moreau; Hermann Einsele; Mario Boccadoro; Jesus San Miguel; Meletios A Dimopoulos; Pieter Sonneveld
Journal:  Leukemia       Date:  2020-05-22       Impact factor: 12.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.